• Home
  • About
  • Webcasts
  • ‘Enforcement 40’ for 2020
  • Enforcement Hall of Fame
  • Contact
Securities Docket
Ankura 480x60
  • Class Actions
  • Criminal
  • Global
  • People
  • SD Insider
  • SEC
  • Video
  • Subscribe by email
  • Subscribe
Browse: Home / 2011 / November / 11 / Stanford May No Longer Be Addicted to Anti-Anxiety Drugs, But Now He Says He Has Amnesia

Stanford May No Longer Be Addicted to Anti-Anxiety Drugs, But Now He Says He Has Amnesia

By Securities Docket on November 11, 2011, 7:11 pm

It appears that Allen Stanford may have finally weaned himself off of the anti-anxiety drug Klonopin. But now he says he has a new ailment that will further delay the case. According to an attorney representing many Stanford investors trying to get their money back, “Allen Stanford says he has amnesia. He can’t remember anything about his past and what he did for 20 years there in Antigua.”

Read more: Stanford May No Longer Be Addicted to Anti-Anxiety Drugs, But Now He Says He Has Amnesia — Enforcement Action

Blog Widget by LinkWithin

Posted in Criminal, Top | Tagged Trials

« Previous Next »

‘Enforcement 40’ for 2020

Securities-Docket_Medium-Rectangle_CaseStudyArrow

Our Sponsors

Securities-Docket_260x125_14Sec Ankura 260x125

Join Us On LinkedIn

Join the Securities Litigation and Enforcement Group on LinkedIn

Archives

Copyright © 2021 Securities Docket.

Powered by WordPress and Hybrid.